LMR Partners LLP acquired a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 141,785 shares of the construction company's stock, valued at approximately $1,684,000. LMR Partners LLP owned about 0.17% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently modified their holdings of ASPN. AlphaQuest LLC raised its position in shares of Aspen Aerogels by 54.0% in the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after purchasing an additional 3,998 shares during the period. KLP Kapitalforvaltning AS bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $164,000. Connors Investor Services Inc. bought a new stake in Aspen Aerogels in the 4th quarter valued at $168,000. Journey Strategic Wealth LLC bought a new position in shares of Aspen Aerogels during the 4th quarter worth about $178,000. Finally, Ballentine Partners LLC raised its position in Aspen Aerogels by 19.2% in the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after purchasing an additional 2,565 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.
Analyst Upgrades and Downgrades
ASPN has been the topic of a number of recent analyst reports. B. Riley reduced their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research report on Wednesday, February 19th. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Craig Hallum lowered their price target on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Finally, Oppenheimer cut shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $19.11.
Get Our Latest Stock Analysis on ASPN
Aspen Aerogels Stock Down 1.3%
Shares of NYSE:ASPN traded down $0.09 during mid-day trading on Monday, reaching $6.26. 998,350 shares of the stock were exchanged, compared to its average volume of 1,961,513. The company has a market cap of $513.57 million, a P/E ratio of 39.10 and a beta of 2.72. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $33.15. The stock's 50 day simple moving average is $5.89 and its 200-day simple moving average is $10.02. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm had revenue of $78.72 million during the quarter, compared to analysts' expectations of $82.75 million. During the same period in the prior year, the firm posted ($0.02) earnings per share. The business's quarterly revenue was down 16.7% compared to the same quarter last year. As a group, equities research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.
Insider Buying and Selling
In related news, CEO Donald R. Young acquired 20,000 shares of the firm's stock in a transaction on Monday, May 12th. The shares were purchased at an average cost of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 550,856 shares in the company, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 4.30% of the stock is currently owned by corporate insiders.
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.